Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
| Image |  |
|---|---|
| Description | scientific article published on 01 December 2018 |
| Author/s |
author: David A Skerrett-Byrne Matthew D Dun |
| Publication date | December 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |